 |
 |
 |
|
- DLL4 is a new Biomarker of Cardiometabolic disorders.
- Monoclonal Antibody pair specific to Human soluble DLL4
- Assay Range: 31.25 ~ 2000 pg/mL
- Sensitivity: 10 pg/mL
- Calibration: human sDLL4 (HEK293)
- Specificity: human DLL4
- Sample Type: serum, plasma, recombinant protein
- Size: 96 T
- Price: $490 per 96T; $940 per 192T
- Protocol: SK00538-01
- Updated on 25 Aug.,, 2023
Research References:
- Fujimaki S, Matsumoto T, Muramatsu M, Nagahisa H, Horii N, Seko D, Masuda S, Wang X, Asakura Y, Takahashi Y, Miyamoto Y, Usuki S, Yasunaga KI, Kamei Y, Nishinakamura R, Minami T, Fukuda T, Asakura A, Ono Y. The endothelial Dll4-muscular Notch2 axis regulates skeletal muscle mass. Nat Metab. 2022 Feb;4(2):180-189. PMID: 35228746.
- Alex Aupetit , et al. Endothelial DLL4 Is an Adipose Depot-Specific Fasting Sensor Regulating Fatty Acid Fluxes. Arterioscler Thromb Vasc Biol. 2023 May;43(5):684-696
- Yang S, et al. KLF13 restrains Dll4-muscular Notch2 axis to improve the muscle atrophy. J Cachexia Sarcopenia Muscle. 2024 Jul 8. Epub ahead of print. PMID: 38973459
 
|
|
|
 |
|
 |
|